Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment

Gynecological Endocrinology

Volumn 27, Issue 8, 2011, Pages 524-528

  Poomthavorn, Preamrudee ^a   Suphasit, Ratchadaporn ^a   Mahachoklertwattana, Pat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

adult height; bone age; Central precocious puberty; gonadotropin releasing hormone analogue; predicted adult height

Indexed keywords

GONADORELIN; LEUPRORELIN; LUTEINIZING HORMONE; TRIPTORELIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE AGE; BREAST DEVELOPMENT; CENTRAL PRECOCIOUS PUBERTY; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GONAD FUNCTION; GROWTH ACCELERATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IDIOPATHIC DISEASE; LONG TERM CARE; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD;

ADOLESCENT; ADOLESCENT DEVELOPMENT; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD DEVELOPMENT; FEMALE; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; GROWTH DISORDERS; HUMANS; MENARCHE; PUBERTY, PRECOCIOUS;

EID: 79959931994     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.507289     Document Type: Article

References (30)

1. Crowley WF Jr, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB Jr. Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981;52:370-372. (Pubitemid 11183641)
2. Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog: impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab 2008;93:190-195.
3. Brito VN, Latronico AC, Cukier P, Teles MG, Silveira LF, Arnhold IJ, Mendonca BB. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 2008;93:2662-2669. (Pubitemid 352008534)
4. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001;86: 4711-4716. (Pubitemid 33020510)
5. Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999;84:4583-4590.
6. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999;141:140-144. (Pubitemid 29402217)
7. Kletter GB, Kelch RP. Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994;79:331-334.
8. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, Jansen M, Gerver WJ, Waelkens J, Drop S. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996;75: 292-297. (Pubitemid 26354598)
9. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 1999;84:1973-1978. (Pubitemid 30647019)
10. Paterson WF, McNeill E, Young D, Donaldson MD. Auxological outcome and time to menarche following longacting goserelin therapy in girls with central precocious or early puberty. Clin Endocrinol 2004;61:626-634. (Pubitemid 39540366)
11. Traggiai C, Perucchin PP, Zerbini K, Gastaldi R, De Biasio P, Lorini R. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height. Eur J Endocrinol 2005;153:463-464. (Pubitemid 41410503)
12. Partsch CJ, Hummelink R, Sippell WG. Reference ranges of lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradiometric assay. J Clin Chem Clin Biochem 1990;28:49-52. (Pubitemid 20058991)
13. Poomthavorn P, Khlairit P, Mahachoklertwattana P. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty. Horm Res 2009;72:114-119.
14. Bhatia S, Neely EK, Wilson DM. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 2002;109: E30.
15. Department of Health, Ministry of Public Health, Thailand. Reference for weight, height and nutritional indices in Thais aged 1 day to 19 years. Bangkok, Thailand: Department of Health, Ministry of Public Health, Thailand; 2000.
16. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 1970;45:755-762.
17. WHO growth reference data for 5-19 years. 2007 WHO reference. Electronic citation. http://www.who.int/growthref/ en/ Accessed 24 August 2009.
18. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
19. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press; 1959.
20. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952;40:423-441.
21. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue.Acomparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997;47:54-61. (Pubitemid 27045987)
22. Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Borrelli P, Osio D, Mengarda F, De Luca F, et al. End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13:773-780.
23. Carel JC, Lahlou N, Roger M, Chaussain JL. Precocious puberty and statural growth. Hum Reprod Update 2004;10: 135-147. (Pubitemid 38519334)
24. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 1995;126:955-958.
25. Chiumello G, Brambilla P, Guarneri MP, Russo G, Manzoni P, Sgaramella P. Precocious puberty and body composition: effects of GnRH analog treatment. J Pediatr Endocrinol Metab 2000;13:791-794.
26. Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB Jr. Reproductive axis after discontinuation of gonadotropinreleasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 1999;84:44-49. (Pubitemid 29036678)
27. Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Segni M, Rosano M, Messina MF, Lombardo F. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur J Endocrinol 2004;150:533-537. (Pubitemid 38584705)
28. Magiakou MA, Manousaki D, Papadaki M, Hadjidakis D, Levidou G, Vakaki M, Papaefstathiou A, Lalioti N, Kanaka-Gantenbein C, Piaditis G, et al. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab 2010;95:109-117.
29. Schroor EJ, Van Weissenbruch MM, Delemarre-van de Waal HA. Long-term GnRH-agonist treatment does not postpone central development of the GnRH pulse generator in girls with idiopathic precocious puberty. J Clin Endocrinol Metab 1995;80:1696-1701.
30. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR; ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752-e762.